CG Oncology to Present at Upcoming Investor Conferences in June

CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference this month. The details of the upcoming events are as follows:

Jefferies Global Healthcare Conference Date: Wednesday, June 3, 2026 Presentation Time: 10:30-11:00 AM ET Location: New York, New York

Goldman Sachs 47th Annual Global Healthcare Conference Date: Tuesday, June 9, 2026 Presentation Time: 2:40-3:15 PM ET Location: Miami, Florida

Interested parties may access the live audio webcast for the conferences from the Investor Relations section of the company's website at www.cgoncology.com . The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.

About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.

Contacts

Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com

Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com